Back to Table of Top Pathways

Erlotinib

GeneID Mean_1 Mean_3 StDev_1 StDev_3 T-Statistic p-value SymbolDescription
1 19 3.0 2.4 0.6 0.1 -1.605 0.2442 ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1
2 9429 2.8 6.4 0.5 0.3 11.391 0.0013 ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
3 22985 10.0 10.2 0.1 0.1 2.723 0.0704 ACIN1 apoptotic chromatin condensation inducer 1
4 196 9.6 8.4 0.3 0.2 -6.697 0.0045 AHR aryl hydrocarbon receptor
5 231 2.7 5.8 0.3 0.1 16.078 0.0023 AKR1B1 aldo-keto reductase family 1, member B1 (aldose reductase)
6 238 2.5 2.5 0.1 0.1 0.197 0.8553 ALK anaplastic lymphoma receptor tyrosine kinase
7 367 12.4 12.2 0.1 0.2 -1.364 0.2484 AR androgen receptor
8 51761 2.8 4.2 0.2 0.2 8.068 0.0017 ATP8A2 ATPase, aminophospholipid transporter, class I, type 8A, member 2
9 9212 8.7 10.0 0.2 0.2 7.824 0.0014 AURKB aurora kinase B
10 596 10.3 10.3 0.2 0.1 0.739 0.5268 BCL2 B-cell CLL/lymphoma 2
11 637 13.4 12.8 0.2 0.2 -3.251 0.0322 BID BH3 interacting domain death agonist
12 672 9.9 10.0 0.0 0.4 0.374 0.7433 BRCA1 breast cancer 1, early onset
13 78996 9.9 11.0 0.2 0.1 9.881 0.0048 C7orf49 chromosome 7 open reading frame 49
14 836 8.2 8.0 0.3 0.2 -1.211 0.3082 CASP3 caspase 3, apoptosis-related cysteine peptidase
15 891 11.3 12.0 0.1 0.2 4.535 0.0280 CCNB1 cyclin B1
16 55536 9.5 8.5 0.2 0.1 -6.800 0.0050 CDCA7L cell division cycle associated 7-like
17 1000 3.2 3.2 0.4 0.1 0.188 0.8677 CDH2 cadherin 2, type 1, N-cadherin (neuronal)
18 1029 6.0 6.5 0.4 0.0 2.330 0.1427 CDKN2A cyclin-dependent kinase inhibitor 2A
19 81620 13.0 13.5 0.6 0.1 1.278 0.3241 CDT1 chromatin licensing and DNA replication factor 1
20 1084 2.6 3.0 0.3 0.7 0.902 0.4445 CEACAM3 carcinoembryonic antigen-related cell adhesion molecule 3
21 57396 8.6 9.0 0.3 0.3 1.354 0.2472 CLK4 CDC-like kinase 4
22 83548 10.1 10.1 0.0 0.2 0.698 0.5574 COG3 component of oligomeric golgi complex 3
23 1437 2.3 2.3 0.0 0.0 0.420 0.7020 CSF2 colony stimulating factor 2 (granulocyte-macrophage)
24 114757 13.4 13.0 0.1 0.2 -2.755 0.0760 CYGB cytoglobin
25 1588 2.3 2.8 0.0 0.4 2.449 0.1329 CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 1
26 1558 2.2 2.8 0.0 0.6 1.477 0.2775 CYP2C8 cytochrome P450, family 2, subfamily C, polypeptide 8
27 4921 2.6 2.9 0.4 0.4 0.964 0.3899 DDR2 discoidin domain receptor tyrosine kinase 2
28 1666 11.2 10.5 0.2 0.3 -3.384 0.0309 DECR1 2,4-dienoyl CoA reductase 1, mitochondrial
29 1950 2.3 2.4 0.0 0.1 1.016 0.4144 EGF epidermal growth factor
30 1956 2.9 3.3 0.2 0.1 3.112 0.0782 EGFR epidermal growth factor receptor
31 1973 14.2 14.4 0.0 0.1 4.859 0.0152 EIF4A1 eukaryotic translation initiation factor 4A1
32 1999 10.5 10.5 0.1 0.7 0.018 0.9875 ELF3 E74-like factor 3 (ets domain transcription factor, epithelial-specific )
33 27436 11.9 12.3 0.1 0.0 4.717 0.0311 EML4 echinoderm microtubule associated protein like 4
34 2048 5.7 5.8 0.3 0.2 0.700 0.5288 EPHB2 EPH receptor B2
35 2064 9.7 9.0 0.4 0.3 -2.344 0.0865 ERBB2 erb-b2 receptor tyrosine kinase 2
36 2065 9.6 9.3 0.1 0.2 -2.412 0.0886 ERBB3 erb-b2 receptor tyrosine kinase 3
37 2066 7.9 5.6 0.2 0.3 -11.036 0.0005 ERBB4 erb-b2 receptor tyrosine kinase 4
38 2099 11.4 9.4 0.1 0.2 -16.793 0.0003 ESR1 estrogen receptor 1
39 2321 2.4 2.5 0.1 0.1 0.409 0.7102 FLT1 fms-related tyrosine kinase 1
40 2580 9.3 8.8 0.1 0.2 -3.432 0.0445 GAK cyclin G associated kinase
41 2996 2.3 2.3 0.0 0.0 -0.435 0.6861 GYPE glycophorin E (MNS blood group)
42 3014 13.3 13.7 0.1 0.2 2.466 0.0809 H2AFX H2A histone family, member X
43 3265 10.7 10.7 0.2 0.4 -0.278 0.8001 HRAS Harvey rat sarcoma viral oncogene homolog
44 3480 12.9 12.8 0.3 0.2 -0.296 0.7828 IGF1R insulin-like growth factor 1 receptor
45 3484 2.4 2.2 0.2 0.0 -0.937 0.4466 IGFBP1 insulin-like growth factor binding protein 1
46 3569 2.3 2.3 0.0 0.0 -0.440 0.6964 IL6 interleukin 6
47 3717 7.8 9.0 0.2 0.4 5.183 0.0187 JAK2 Janus kinase 2
48 3791 2.4 2.3 0.0 0.1 -0.496 0.6472 KDR kinase insert domain receptor
49 57650 2.6 2.7 0.2 0.3 0.448 0.6816 KIAA1524 KIAA1524
50 3815 2.3 2.3 0.1 0.0 -0.184 0.8629 KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
51 3880 18.2 18.4 0.1 0.0 3.350 0.0508 KRT19 keratin 19, type I
52 3854 2.3 4.2 0.1 1.2 2.630 0.1181 KRT6B keratin 6B, type II
53 3939 13.5 13.5 0.2 0.3 0.040 0.9697 LDHA lactate dehydrogenase A
54 4214 11.6 11.1 0.1 0.1 -4.921 0.0154 MAP3K1 mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
55 5595 8.9 9.2 0.3 0.1 1.920 0.1525 MAPK3 mitogen-activated protein kinase 3
56 4233 9.9 11.6 0.1 0.1 28.016 0.0001 MET MET proto-oncogene, receptor tyrosine kinase
57 4318 10.6 9.4 0.1 0.3 -6.225 0.0138 MMP9 matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
58 2475 8.9 9.1 0.0 0.1 3.319 0.0559 MTOR mechanistic target of rapamycin (serine/threonine kinase)
59 4609 8.9 8.0 0.4 0.6 -2.174 0.1053 MYC v-myc avian myelocytomatosis viral oncogene homolog
60 4691 15.3 15.0 0.0 0.3 -1.484 0.2676 NCL nucleolin
61 4780 3.0 4.4 0.8 2.1 1.080 0.3704 NFE2L2 nuclear factor, erythroid 2-like 2
62 2908 9.6 12.1 0.2 0.2 12.739 0.0002 NR3C1 nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
63 3084 2.6 2.6 0.2 0.1 -0.234 0.8278 NRG1 neuregulin 1
64 10133 7.3 7.4 0.2 0.1 1.199 0.3034 OPTN optineurin
65 10038 11.1 11.8 0.3 0.3 3.112 0.0358 PARP2 poly (ADP-ribose) polymerase 2
66 5077 2.9 3.2 0.4 0.3 1.051 0.3563 PAX3 paired box 3
67 5111 12.0 13.1 0.2 0.4 4.276 0.0250 PCNA proliferating cell nuclear antigen
68 255738 2.3 2.4 0.0 0.2 1.182 0.3583 PCSK9 proprotein convertase subtilisin/kexin type 9
69 283871 9.2 9.5 0.2 0.4 1.469 0.2460 PGP phosphoglycolate phosphatase
70 5241 10.2 11.5 0.2 0.1 9.929 0.0013 PGR progesterone receptor
71 5293 3.8 3.0 0.6 0.2 -2.016 0.1586 PIK3CD phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
72 55558 11.7 11.8 0.2 0.2 0.458 0.6717 PLXNA3 plexin A3
73 5468 2.3 4.0 0.0 0.5 5.713 0.0291 PPARG peroxisome proliferator-activated receptor gamma
74 5728 10.1 9.8 0.0 0.1 -3.208 0.0714 PTEN phosphatase and tensin homolog
75 2185 9.1 8.2 0.0 0.4 -4.284 0.0472 PTK2B protein tyrosine kinase 2 beta
76 5923 3.0 2.3 1.2 0.1 -0.992 0.4255 RASGRF1 Ras protein-specific guanine nucleotide-releasing factor 1
77 6098 4.4 2.6 0.3 0.5 -5.609 0.0063 ROS1 ROS proto-oncogene 1 , receptor tyrosine kinase
78 6185 12.8 13.3 0.1 0.1 6.250 0.0058 RPN2 ribophorin II
79 677775 7.5 7.5 0.1 0.1 -0.090 0.9327 SCARNA5 small Cajal body-specific RNA 5
80 9644 3.4 2.9 0.4 0.4 -1.640 0.1765 SH3PXD2A SH3 and PX domains 2A
81 6581 2.4 2.4 0.0 0.1 0.029 0.9782 SLC22A3 solute carrier family 22 (organic cation transporter), member 3
82 9748 9.5 9.6 0.1 0.2 0.590 0.6044 SLK STE20-like kinase
83 9126 11.5 11.9 0.1 0.2 2.424 0.0778 SMC3 structural maintenance of chromosomes 3
84 23583 9.9 9.9 0.1 0.0 0.634 0.5814 SMUG1 single-strand-selective monofunctional uracil-DNA glycosylase 1
85 6714 6.5 7.6 0.1 0.1 13.718 0.0002 SRC SRC proto-oncogene, non-receptor tyrosine kinase
86 6774 7.9 7.4 0.2 0.1 -4.219 0.0140 STAT3 signal transducer and activator of transcription 3 (acute-phase response factor)
87 55775 11.6 11.9 0.0 0.1 4.751 0.0210 TDP1 tyrosyl-DNA phosphodiesterase 1
88 7030 9.5 9.5 0.1 0.1 0.636 0.5634 TFE3 transcription factor binding to IGHM enhancer 3
89 7157 7.9 7.4 0.3 0.5 -1.440 0.2378 TP53 tumor protein p53
90 7248 7.0 6.6 0.5 0.0 -1.693 0.2299 TSC1 tuberous sclerosis 1
91 7298 12.8 13.6 0.0 0.4 3.424 0.0753 TYMS thymidylate synthetase
92 7422 8.5 8.5 0.5 0.2 0.009 0.9937 VEGFA vascular endothelial growth factor A
93 7431 4.9 6.7 0.5 0.1 6.548 0.0153 VIM vimentin
94 7525 9.9 9.8 0.1 0.1 -0.554 0.6091 YES1 YES proto-oncogene 1, Src family tyrosine kinase
95 22882 9.6 10.2 0.1 0.3 3.424 0.0581 ZHX2 zinc fingers and homeoboxes 2